Clinical Trial Update: Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism [Phase 4]

View source ↗

Summary

Phase 4 trial update for the optimum duration of acoustic pulse thrombolysis in acute pulmonary embolism; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Pulmonary Embolism and Thrombosis | Phase 4 | Status: COMPLETED | Results posted: 2021-03-02